Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cigna Corp (CI) vs Equinor ASA (EQNR) Price & Performance

Cigna CorpTrade
Equinor ASATrade

Price performance (Past 24H)

Key statistics

Cigna Corp vs Equinor ASA — how do they compare? Cigna Corp trades at $299.99 (market cap $80.25B), while Equinor ASA trades at $36.12 (market cap $83.20B). The key difference: Cigna Corp and Equinor ASA are close in size by market cap, and Equinor ASA pays the higher dividend (4.2%). Which is the better fit depends on your goals.

CIEQNR
Market Cap
$80.25B$83.20B
Sector
HealthEnergy
52-Week High
$311.00$42.40
52-Week Low
$244.41$22.41
Enterprise Value
$103.35B$94.96B
Dividend Yield
2.06%4.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cigna Corp

Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.

The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.

Equinor ASA

Equinor (EQNR) trades at $36.06, up 6.31% with a bullish technical outlook despite mixed earnings. The stock shows strong profitability with 37.45% gross margins and attractive valuation metrics including a P/E of 16.32 and EV/EBITDA of 2.37. Recent strategic moves include expanding Norwegian Continental Shelf operations through $410M Troll field investment and acquiring BP's Bay du Nord stake, positioning for production growth.

EQNR presents a balanced opportunity with solid fundamentals and strategic growth initiatives, though declining revenue and net income trends warrant monitoring. Analyst sentiment is mixed with 30% buy ratings, while technical indicators suggest near-term strength. Key risks include volatile energy prices and execution challenges in new projects.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI

About Equinor ASA

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

Read more on EQNR